nodes	percent_of_prediction	percent_of_DWPC	metapath
Troleandomycin—CYP3A43—Dexamethasone—multiple sclerosis	0.257	0.277	CbGbCtD
Troleandomycin—CYP2A6—Prednisolone—multiple sclerosis	0.0929	0.1	CbGbCtD
Troleandomycin—CYP2A6—Dexamethasone—multiple sclerosis	0.0548	0.059	CbGbCtD
Troleandomycin—ABCB1—Methylprednisolone—multiple sclerosis	0.0483	0.0521	CbGbCtD
Troleandomycin—CYP3A4—Fingolimod—multiple sclerosis	0.0449	0.0484	CbGbCtD
Troleandomycin—CYP2C19—Prednisone—multiple sclerosis	0.0363	0.0391	CbGbCtD
Troleandomycin—ABCB1—Mitoxantrone—multiple sclerosis	0.0353	0.038	CbGbCtD
Troleandomycin—ABCB1—Betamethasone—multiple sclerosis	0.0314	0.0338	CbGbCtD
Troleandomycin—ABCB1—Prednisolone—multiple sclerosis	0.031	0.0334	CbGbCtD
Troleandomycin—ABCB1—Prednisone—multiple sclerosis	0.0293	0.0315	CbGbCtD
Troleandomycin—CYP3A4—Methylprednisolone—multiple sclerosis	0.029	0.0312	CbGbCtD
Troleandomycin—CYP3A5—Dexamethasone—multiple sclerosis	0.0281	0.0303	CbGbCtD
Troleandomycin—CYP2C8—Dexamethasone—multiple sclerosis	0.027	0.0291	CbGbCtD
Troleandomycin—CYP2C19—Dexamethasone—multiple sclerosis	0.0227	0.0244	CbGbCtD
Troleandomycin—CYP3A4—Triamcinolone—multiple sclerosis	0.0219	0.0236	CbGbCtD
Troleandomycin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0211	0.0228	CbGbCtD
Troleandomycin—CYP2C9—Dexamethasone—multiple sclerosis	0.0188	0.0203	CbGbCtD
Troleandomycin—CYP3A4—Betamethasone—multiple sclerosis	0.0188	0.0203	CbGbCtD
Troleandomycin—CYP3A4—Prednisolone—multiple sclerosis	0.0186	0.02	CbGbCtD
Troleandomycin—ABCB1—Dexamethasone—multiple sclerosis	0.0183	0.0197	CbGbCtD
Troleandomycin—CYP3A4—Prednisone—multiple sclerosis	0.0175	0.0189	CbGbCtD
Troleandomycin—ABCB1—Methotrexate—multiple sclerosis	0.0147	0.0158	CbGbCtD
Troleandomycin—CYP3A4—Dexamethasone—multiple sclerosis	0.011	0.0118	CbGbCtD
Troleandomycin—CYP2C18—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00111	0.0156	CbGpPWpGaD
Troleandomycin—CYP2C18—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00111	0.0156	CbGpPWpGaD
Troleandomycin—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00102	0.0143	CbGpPWpGaD
Troleandomycin—CYP3A43—Biological oxidations—CYP27B1—multiple sclerosis	0.000977	0.0137	CbGpPWpGaD
Troleandomycin—CYP3A43—Biological oxidations—CYP24A1—multiple sclerosis	0.000977	0.0137	CbGpPWpGaD
Troleandomycin—CYP3A43—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000964	0.0135	CbGpPWpGaD
Troleandomycin—CYP3A43—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000964	0.0135	CbGpPWpGaD
Troleandomycin—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000921	0.0129	CbGpPWpGaD
Troleandomycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000838	0.0117	CbGpPWpGaD
Troleandomycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000838	0.0117	CbGpPWpGaD
Troleandomycin—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000827	0.0116	CbGpPWpGaD
Troleandomycin—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000827	0.0116	CbGpPWpGaD
Troleandomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000786	0.011	CbGpPWpGaD
Troleandomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000786	0.011	CbGpPWpGaD
Troleandomycin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000734	0.0103	CbGpPWpGaD
Troleandomycin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000734	0.0103	CbGpPWpGaD
Troleandomycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000679	0.00951	CbGpPWpGaD
Troleandomycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000679	0.00951	CbGpPWpGaD
Troleandomycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000661	0.00925	CbGpPWpGaD
Troleandomycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000661	0.00925	CbGpPWpGaD
Troleandomycin—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000652	0.00913	CbGpPWpGaD
Troleandomycin—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000652	0.00913	CbGpPWpGaD
Troleandomycin—CYP2C18—Biological oxidations—CYP27B1—multiple sclerosis	0.000592	0.00829	CbGpPWpGaD
Troleandomycin—CYP2C18—Biological oxidations—CYP24A1—multiple sclerosis	0.000592	0.00829	CbGpPWpGaD
Troleandomycin—CYP2C18—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000584	0.00817	CbGpPWpGaD
Troleandomycin—CYP2C18—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000584	0.00817	CbGpPWpGaD
Troleandomycin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000572	0.00801	CbGpPWpGaD
Troleandomycin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000572	0.00801	CbGpPWpGaD
Troleandomycin—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000565	0.00791	CbGpPWpGaD
Troleandomycin—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000565	0.00791	CbGpPWpGaD
Troleandomycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000536	0.0075	CbGpPWpGaD
Troleandomycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000536	0.0075	CbGpPWpGaD
Troleandomycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000511	0.00715	CbGpPWpGaD
Troleandomycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000511	0.00715	CbGpPWpGaD
Troleandomycin—CYP3A43—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000511	0.00715	CbGpPWpGaD
Troleandomycin—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000504	0.00706	CbGpPWpGaD
Troleandomycin—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000504	0.00706	CbGpPWpGaD
Troleandomycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000484	0.00677	CbGpPWpGaD
Troleandomycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000484	0.00677	CbGpPWpGaD
Troleandomycin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000466	0.00652	CbGpPWpGaD
Troleandomycin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000466	0.00652	CbGpPWpGaD
Troleandomycin—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000464	0.00649	CbGpPWpGaD
Troleandomycin—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000464	0.00649	CbGpPWpGaD
Troleandomycin—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00046	0.00643	CbGpPWpGaD
Troleandomycin—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00046	0.00643	CbGpPWpGaD
Troleandomycin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000447	0.00626	CbGpPWpGaD
Troleandomycin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000428	0.006	CbGpPWpGaD
Troleandomycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000414	0.0058	CbGpPWpGaD
Troleandomycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000414	0.0058	CbGpPWpGaD
Troleandomycin—CYP3A43—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000414	0.00579	CbGpPWpGaD
Troleandomycin—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000378	0.00529	CbGpPWpGaD
Troleandomycin—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000378	0.00529	CbGpPWpGaD
Troleandomycin—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000361	0.00505	CbGpPWpGaD
Troleandomycin—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000361	0.00505	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.00034	0.00476	CbGpPWpGaD
Troleandomycin—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000309	0.00433	CbGpPWpGaD
Troleandomycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000307	0.0043	CbGpPWpGaD
Troleandomycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000307	0.0043	CbGpPWpGaD
Troleandomycin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000303	0.00424	CbGpPWpGaD
Troleandomycin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000303	0.00424	CbGpPWpGaD
Troleandomycin—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000285	0.00398	CbGpPWpGaD
Troleandomycin—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000285	0.00398	CbGpPWpGaD
Troleandomycin—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000281	0.00393	CbGpPWpGaD
Troleandomycin—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000281	0.00393	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000277	0.00388	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000277	0.00388	CbGpPWpGaD
Troleandomycin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000276	0.00386	CbGpPWpGaD
Troleandomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000257	0.0036	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000252	0.00353	CbGpPWpGaD
Troleandomycin—CYP2C18—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000251	0.00351	CbGpPWpGaD
Troleandomycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000249	0.00349	CbGpPWpGaD
Troleandomycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000249	0.00349	CbGpPWpGaD
Troleandomycin—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000246	0.00345	CbGpPWpGaD
Troleandomycin—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000246	0.00345	CbGpPWpGaD
Troleandomycin—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000243	0.0034	CbGpPWpGaD
Troleandomycin—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000243	0.0034	CbGpPWpGaD
Troleandomycin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00024	0.00336	CbGpPWpGaD
Troleandomycin—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000239	0.00335	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000238	0.00333	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—SRM—multiple sclerosis	0.000237	0.00332	CbGpPWpGaD
Troleandomycin—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.00022	0.00308	CbGpPWpGaD
Troleandomycin—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.00022	0.00308	CbGpPWpGaD
Troleandomycin—CYP3A43—Biological oxidations—POMC—multiple sclerosis	0.00022	0.00308	CbGpPWpGaD
Troleandomycin—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000217	0.00304	CbGpPWpGaD
Troleandomycin—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000217	0.00304	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000216	0.00302	CbGpPWpGaD
Troleandomycin—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000201	0.00281	CbGpPWpGaD
Troleandomycin—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000201	0.00281	CbGpPWpGaD
Troleandomycin—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000198	0.00277	CbGpPWpGaD
Troleandomycin—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000198	0.00277	CbGpPWpGaD
Troleandomycin—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000189	0.00264	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000187	0.00262	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000182	0.00255	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000174	0.00244	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000173	0.00242	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—CYP27B1—multiple sclerosis	0.000167	0.00234	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—CYP24A1—multiple sclerosis	0.000167	0.00234	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000166	0.00233	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000164	0.00229	CbGpPWpGaD
Troleandomycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000158	0.00222	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—GPC5—multiple sclerosis	0.000153	0.00214	CbGpPWpGaD
Troleandomycin—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000153	0.00214	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00015	0.00209	CbGpPWpGaD
Troleandomycin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000149	0.00208	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000144	0.00202	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—SRM—multiple sclerosis	0.000144	0.00201	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000135	0.00189	CbGpPWpGaD
Troleandomycin—CYP2C18—Biological oxidations—POMC—multiple sclerosis	0.000133	0.00186	CbGpPWpGaD
Troleandomycin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000132	0.00185	CbGpPWpGaD
Troleandomycin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000132	0.00185	CbGpPWpGaD
Troleandomycin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00013	0.00183	CbGpPWpGaD
Troleandomycin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00013	0.00183	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.00013	0.00182	CbGpPWpGaD
Troleandomycin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000129	0.0018	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000127	0.00178	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000127	0.00178	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—RRM1—multiple sclerosis	0.000127	0.00177	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000124	0.00173	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000121	0.0017	CbGpPWpGaD
Troleandomycin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000121	0.00169	CbGpPWpGaD
Troleandomycin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000115	0.00161	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000114	0.0016	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000114	0.00159	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000112	0.00157	CbGpPWpGaD
Troleandomycin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000105	0.00147	CbGpPWpGaD
Troleandomycin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000104	0.00146	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000103	0.00144	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	0.000101	0.00142	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	0.000101	0.00142	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	9.47e-05	0.00133	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.47e-05	0.00132	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.47e-05	0.00132	CbGpPWpGaD
Troleandomycin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.32e-05	0.0013	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—GPC5—multiple sclerosis	9.26e-05	0.0013	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—SRM—multiple sclerosis	8.76e-05	0.00123	CbGpPWpGaD
Troleandomycin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.5e-05	0.00119	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.45e-05	0.00118	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.45e-05	0.00118	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.43e-05	0.00118	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.2e-05	0.00115	CbGpPWpGaD
Troleandomycin—CYP2A6—Biological oxidations—POMC—multiple sclerosis	8.12e-05	0.00114	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.7e-05	0.00108	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.7e-05	0.00108	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—RRM1—multiple sclerosis	7.68e-05	0.00107	CbGpPWpGaD
Troleandomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.63e-05	0.00107	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.49e-05	0.00105	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—BCHE—multiple sclerosis	7.28e-05	0.00102	CbGpPWpGaD
Troleandomycin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.91e-05	0.000967	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—SRM—multiple sclerosis	6.91e-05	0.000967	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.68e-05	0.000935	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.65e-05	0.000931	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.58e-05	0.000921	CbGpPWpGaD
Troleandomycin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.4e-05	0.000896	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.39e-05	0.000895	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	6.17e-05	0.000864	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	6.17e-05	0.000864	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—SRM—multiple sclerosis	5.98e-05	0.000837	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—GPC5—multiple sclerosis	5.64e-05	0.00079	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.63e-05	0.000789	CbGpPWpGaD
Troleandomycin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.6e-05	0.000784	CbGpPWpGaD
Troleandomycin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.54e-05	0.000776	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—SRM—multiple sclerosis	5.34e-05	0.000747	CbGpPWpGaD
Troleandomycin—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	5.34e-05	0.000747	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—SRM—multiple sclerosis	5.21e-05	0.00073	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.19e-05	0.000727	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.05e-05	0.000707	CbGpPWpGaD
Troleandomycin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.95e-05	0.000693	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—SRM—multiple sclerosis	4.87e-05	0.000682	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.87e-05	0.000681	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.87e-05	0.000681	CbGpPWpGaD
Troleandomycin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.85e-05	0.000678	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—RRM1—multiple sclerosis	4.68e-05	0.000655	CbGpPWpGaD
Troleandomycin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.51e-05	0.000632	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.47e-05	0.000625	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.45e-05	0.000623	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—BCHE—multiple sclerosis	4.41e-05	0.000617	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—APOE—multiple sclerosis	4.38e-05	0.000613	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.22e-05	0.00059	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.22e-05	0.00059	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.12e-05	0.000577	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.86e-05	0.00054	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.76e-05	0.000527	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.76e-05	0.000527	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—POMC—multiple sclerosis	3.76e-05	0.000526	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.69e-05	0.000516	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.68e-05	0.000515	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.67e-05	0.000514	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.67e-05	0.000514	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.44e-05	0.000482	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.43e-05	0.00048	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.43e-05	0.00048	CbGpPWpGaD
Troleandomycin—CYP3A43—Metabolism—ALB—multiple sclerosis	3.43e-05	0.00048	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—GPC5—multiple sclerosis	3.36e-05	0.00047	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.35e-05	0.000469	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—SRM—multiple sclerosis	3.21e-05	0.000449	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.19e-05	0.000447	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.14e-05	0.000439	CbGpPWpGaD
Troleandomycin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.98e-05	0.000417	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.85e-05	0.000399	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—RRM1—multiple sclerosis	2.78e-05	0.00039	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.69e-05	0.000376	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—APOE—multiple sclerosis	2.65e-05	0.000371	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.6e-05	0.000364	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.57e-05	0.000359	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.56e-05	0.000359	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.51e-05	0.000352	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.48e-05	0.000347	CbGpPWpGaD
Troleandomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.39e-05	0.000335	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—POMC—multiple sclerosis	2.28e-05	0.000319	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.26e-05	0.000317	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.26e-05	0.000317	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.21e-05	0.00031	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.13e-05	0.000298	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000297	CbGpPWpGaD
Troleandomycin—CYP2C18—Metabolism—ALB—multiple sclerosis	2.08e-05	0.000291	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.07e-05	0.00029	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.02e-05	0.000282	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.94e-05	0.000272	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.9e-05	0.000266	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.83e-05	0.000257	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.73e-05	0.000243	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.73e-05	0.000243	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.00024	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000229	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—APOE—multiple sclerosis	1.62e-05	0.000226	CbGpPWpGaD
Troleandomycin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.61e-05	0.000225	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—BCHE—multiple sclerosis	1.6e-05	0.000224	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.58e-05	0.000221	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000209	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—POMC—multiple sclerosis	1.39e-05	0.000194	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—APOE—multiple sclerosis	1.27e-05	0.000178	CbGpPWpGaD
Troleandomycin—CYP2A6—Metabolism—ALB—multiple sclerosis	1.27e-05	0.000177	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—APOE—multiple sclerosis	1.1e-05	0.000154	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—POMC—multiple sclerosis	1.09e-05	0.000153	CbGpPWpGaD
Troleandomycin—CYP3A5—Metabolism—ALB—multiple sclerosis	9.98e-06	0.00014	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—APOE—multiple sclerosis	9.85e-06	0.000138	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.85e-06	0.000138	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—APOE—multiple sclerosis	9.62e-06	0.000135	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—POMC—multiple sclerosis	9.48e-06	0.000133	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—APOE—multiple sclerosis	8.98e-06	0.000126	CbGpPWpGaD
Troleandomycin—CYP2C8—Metabolism—ALB—multiple sclerosis	8.65e-06	0.000121	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—POMC—multiple sclerosis	8.46e-06	0.000118	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—POMC—multiple sclerosis	8.26e-06	0.000116	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—POMC—multiple sclerosis	7.72e-06	0.000108	CbGpPWpGaD
Troleandomycin—CYP2C19—Metabolism—ALB—multiple sclerosis	7.72e-06	0.000108	CbGpPWpGaD
Troleandomycin—ABCB1—Metabolism—ALB—multiple sclerosis	7.53e-06	0.000105	CbGpPWpGaD
Troleandomycin—CYP2C9—Metabolism—ALB—multiple sclerosis	7.04e-06	9.85e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—APOE—multiple sclerosis	5.92e-06	8.29e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—POMC—multiple sclerosis	5.09e-06	7.12e-05	CbGpPWpGaD
Troleandomycin—CYP3A4—Metabolism—ALB—multiple sclerosis	4.64e-06	6.49e-05	CbGpPWpGaD
